Hyaluronic acid in drug delivery applications

Abstract Hyaluronic acid (HA), a natural polysaccharide with good biocompatibility and biodegradability, is pivotal for many cellular and tissue functions and has been in clinical use for decades. Based upon other characteristics such as water-binding ability, viscoelastic properties, and nonimmunogenicity, HA turns to be an ideal candidate for several medical and pharmaceutical applications. It not only serves as a cross-linking agent among other nanocomposite drug delivery systems but also can form self-assembling systems as an amphiphilic molecule. Besides, it can be modified by grafting, cross-linking, linking with hydrophobic substances and drugs, or through polyion complex formation with oppositely charged proteins, polysaccharides, or surfactants. HA and its derivatives can be further employed as sustained-release carriers for drugs, which can postpone the release of drugs and have a long-acting effect. They can be used for the delivery of various drugs such as proteins/peptides, nucleic acids, and antitumor drugs. This chapter is aimed to provide recent updates on HA research, with an emphasis on the outstanding physicochemical properties of HA derivatives and their applications in drug delivery systems. This chapter also displays a foresight into the magnitude of HA application in the progress of targeted drug vectors and innovative trials of drug delivery systems.

• Publication year

  2019

• Venue

  Natural Polysaccharides in Drug Delivery and Biomedical Applications

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/B978-0-12-817055-7.00013-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyaluronic acid and hyaluronic acid: Sucrose nanogels for hydrophobic cancer drug delivery.

  2019cited by this paper
• Modified hyaluronic acid based materials for biomedical applications.

  2019cited by this paper
• CD44 targeting biocompatible and biodegradable hyaluronic acid cross‐linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation

  2018cited by this paper
• Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustration with firsthand examples

  2018cited by this paper
• Hyaluronic acid‐based biopharmaceutical delivery and tumor‐targeted drug delivery system

  2018cited by this paper
• Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer.

  2018cited by this paper
• Hyaluronic acid-coated cisplatin conjugated gold nanoparticles for combined cancer treatment

  2018cited by this paper
• Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy.

  2018cited by this paper
• Injectable hydrogels based on the hyaluronic acid and poly (γ-glutamic acid) for controlled protein delivery.

  2018cited by this paper
• Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.

  2018cited by this paper
• Tween 80-modified hyaluronic acid-ss-curcumin micelles for targeting glioma: Synthesis, characterization and their in vitro evaluation.

  2018cited by this paper
• Nano-scale drug delivery systems for antiarrhythmic agents.

  2018cited by this paper
• Preparation of sponge-like macroporous PVA hydrogels via n-HA enhanced phase separation and their potential as wound dressing

  2018cited by this paper
• Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride.

  2018cited by this paper
• Advances in Biomaterials for Drug Delivery

  2018cited by this paper
• pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.

  2018cited by this paper
• Effects of molecular weight of hyaluronic acid on its viscosity and enzymatic activities of lysozyme and peroxidase.

  2018cited by this paper
• Hyaluronic Acid and Polyethylene Glycol Hybrid Hydrogel Encapsulating Nanogel with Hemostasis and Sustainable Antibacterial Property for Wound Healing.

  2018cited by this paper
• Synthesis, characterization and liver targeting evaluation of self‐assembled hyaluronic acid nanoparticles functionalized with glycyrrhetinic acid

  2017cited by this paper
• Polysaccharides based nanomaterials for targeted anti-cancer drug delivery

  2017cited by this paper
• Examination of In vitro and In vivo biocompatibility of alginate-hyaluronic acid microbeads As a promising method in cell delivery for kidney regeneration.

  2017cited by this paper
• Hyaluronic Acid and Its Derivatives in Coating and Delivery Systems: Applications in Tissue Engineering, Regenerative Medicine and Immunomodulation

  2016cited by this paper
• Biocompatibility of a Self-Assembled Crosslinkable Hyaluronic Acid Nanogel.

  2016cited by this paper
• Co-delivery of drugs and plasmid DNA for cancer therapy.

  2016cited by this paper
• New progress and prospects: The application of nanogel in drug delivery.

  2016cited by this paper
• Hyaluronic acid for anticancer drug and nucleic acid delivery.

  2016cited by this paper
• Polysaccharide based nanogels in the drug delivery system: Application as the carrier of pharmaceutical agents.

  2016cited by this paper
• Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery.

  2015cited by this paper
• Synthesis of PEGylated hyaluronic acid for loading dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt) in nanoparticles for cancer treatment

  2015cited by this paper
• Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges.

  2015cited by this paper
• Alginate based polyurethanes: A review of recent advances and perspective.

  2015cited by this paper
• Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.

  2014cited by this paper
• Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer

  2014cited by this paper
• Chemical functionalization of hyaluronic acid for drug delivery applications.

  2014cited by this paper
• Effect of hyaluronic acid on the thermogelation and biocompatibility of its blends with methyl cellulose.

  2014cited by this paper
• Non-viral vectors for gene-based therapy

  2014cited by this paper
• PEG - a versatile conjugating ligand for drugs and drug delivery systems.

  2014cited by this paper
• Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications.

  2014cited by this paper
• A novel crosslinked hyaluronic acid nanogel for drug delivery.

  2014cited by this paper
• Current research on hyaluronic acid-drug bioconjugates.

  2014cited by this paper
• Controlled drug delivery systems: past forward and future back.

  2014cited by this paper
• Beneficial effects of hyaluronic acid.

  2014cited by this paper
• The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

  2013cited by this paper
• Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering

  2013cited by this paper
• Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.

  2013cited by this paper
• Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.

  2013cited by this paper
• The effect of hyaluronic acid on biofunctionality of gelatin-collagen intestine tissue engineering scaffolds.

  2013cited by this paper
• Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.

  2013cited by this paper
• Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery.

  2013cited by this paper
• Chitosan-based drug delivery systems.

  2012cited by this paper
• Nanoparticles as drug delivery systems

  2012cited by this paper
• S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties.

  2012cited by this paper
• Injectable hydrogel for sustained protein release by salt-induced association of hyaluronic acid nanogel.

  2012cited by this paper
• A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.

  2011cited by this paper
• Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications

  2011cited by this paper
• Enhanced MSC chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo.

  2011cited by this paper
• Fabrication of alginate/nanoTiO2 needle composite scaffolds for tissue engineering applications

  2011cited by this paper
• Hyaluronic Acid Hydrogels for Biomedical Applications

  2011cited by this paper
• Hyaluronic Acid/Chitosan-g-Poly(ethylene glycol) Nanoparticles for Gene Therapy: An Application for pDNA and siRNA Delivery

  2010cited by this paper
• Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis.

  2010cited by this paper
• Drug delivery to solid tumors by elastin-like polypeptides.

  2010cited by this paper
• Nanostructured hyaluronic acid-based materials for active delivery to cancer

  2010cited by this paper
• Hyaluronic acid and chitosan-DNA complex multilayered thin film as surface-mediated nonviral gene delivery system.

  2009cited by this paper
• CD44 and EpCAM: cancer-initiating cell markers.

  2008cited by this paper
• Polysaccharides-based nanoparticles as drug delivery systems.

  2008cited by this paper
• Hydrogel-based encapsulation of biological, functional tissue: fundamentals, technologies and applications

  2007cited by this paper
• Controlled drug delivery to the lung: Influence of hyaluronic acid solution conformation on its adsorption to hydrophobic drug particles.

  2007cited by this paper
• Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications

  2006cited by this paper
• Biomedical applications of hyaluronic acid

  2006cited by this paper
• Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation.

  2005cited by this paper
• Hyaluronan: from extracellular glue to pericellular cue

  2004cited by this paper
• Effect of pegylation on pharmaceuticals

  2003cited by this paper
• Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer–plasmid complexes

  1999cited by this paper
• Hyaluronic acid-specific regulation of cytokines by human uterine fibroblasts.

  1997cited by this paper
• Hyaluronan in inflammatory joint disease.

  1995cited by this paper
• Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.

  1995cited by this paper
• Effect of addition of hyaluronic acid to highly concentrated insulin on absorption from the conjunctiva in conscious diabetic dogs

  1994cited by this paper
• Uptake of circulating hyaluronic acid by the rat liver

  1985cited by this paper
• THE POLYSACCHARIDE OF THE VITREOUS HUMOR

  1934cited by this paper

• The effects of the molecular weights of hyaluronic acid on the immune responses

  2021cites this paper
• Natural polymer-based magnetic nanohybrids toward biomedical applications

  2021cites this paper